Qualigen Therapeutics, Inc. (QLGN) NASDAQ
3.21
+0.17(+5.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.21
+0.17(+5.59%)
Currency In USD
| Market Cap | 5.71M |
| Enterprise Value | -13.48M |
| P/E Ratio | -0.09 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.06 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.79 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.54 |
| Return On Equity | -1.05 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.2M |
| Net Income | -19.53M |
| Diluted EPS | -8.11 |
| Total Cash | 19.33M |
| Total Cash/Share | 15.42 |
| Total Debt | 142,236 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 9.3 |
| Book Value Per Share | 22.29 |
| 52-Week Change | -17.69 |
| 52-Week High | 8.81 |
| 52-Week Low | 1.61 |
| Moving Average 50 Days | 3.63 |
| Moving Average 200 Days | 3.2 |
| Average Volume | 2.65M |
| Shares Outstanding | 1.69M |
| % Held by Institutions | 5.66 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | November 05, 2024 |